文献速递糖尿病

糖尿病患者的肾功能指标与心血管结局:Hoorn糖尿病照护系统队列研究

Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
PubMed 文献 · Diabetologia · 2022-11-08

该研究基于Hoorn糖尿病照护系统队列,纳入13,657例糖尿病患者,评估每年记录的eGFR和UACR与心肌梗死、冠心病、卒中、心力衰竭及心血管死亡的前瞻性关联。结果显示轻度至中重度eGFR降低与心肌梗死和冠心病风险升高相关,UACR升高与心血管死亡风险升高相关,且UACR与心力衰竭的关联存在性别效应修饰。

要点

  • 轻度降低eGFR(60-90 ml/min per 1.73 m2)与心肌梗死(HR 1.52)和冠心病(HR 1.67)风险升高相关。
  • 中重度降低eGFR(<59 ml/min per 1.73 m2)与心肌梗死(HR 1.69)和冠心病(HR 2.01)风险升高相关。
  • UACR>3.0 mg/mmol的女性较正常UACR者心力衰竭风险显著升高(HR 2.79)。

核心结论

  • 本研究表明糖尿病早期肾损伤的不同表现与多种心血管疾病亚型存在独立且各异的前瞻性关联,提示定期监测eGFR和UACR可能有助于识别特定心血管事件高风险个体。

研究设计与样本

  • 前瞻性队列研究,纳入Hoorn糖尿病照护系统队列中13,657例糖尿病患者(男性53.6%,年龄62.3±12.1岁),使用1998年至2018年间每年记录的eGFR和UACR数据。
  • 采用多变量时间依赖Cox回归模型估计HR和95% CI,eGFR的关联校正UACR值,反之亦然,并分析性别效应修饰。

主要发现

  • 平均随访7年,每1000人年事件率:心肌梗死3.08、冠心病3.72、心力衰竭1.12、卒中0.84、心血管死亡6.25。
  • 与正常eGFR(>90 ml/min per 1.73 m2)相比,轻度降低eGFR(60-90 ml/min per 1.73 m2)与心肌梗死风险升高相关(HR 1.52;95% CI 1.10, 2.12)及冠心病风险升高相关(HR 1.67;95% CI 1.23, 2.26)。
  • 与正常eGFR(>90 ml/min per 1.73 m2)相比,中重度降低eGFR(<59 ml/min per 1.73 m2)与心肌梗死风险升高相关(HR 1.69;95% CI 1.09, 2.64)及冠心病风险升高相关(HR 2.01;95% CI 1.34, 3.02)。
  • 轻度降低eGFR(60-90 ml/min per 1.73 m2)与卒中风险升高相关(HR 2.53;95% CI 1.27, 5.03)。
  • 与正常UACR(<3 mg/mmol)相比,中度升高UACR(3-30 mg/mmol)与心血管死亡风险升高相关(HR 1.87;95% CI 1.41, 2.47),重度升高UACR(>30 mg/mmol)与心血管死亡风险升高相关(HR 2.78;95% CI 1.78, 4.34)。

临床怎么用

  • 作者认为,定期监测eGFR和UACR可能有助于识别特定心血管事件高风险个体。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m2) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. METHODS: We assessed the prospective association between annually recorded measures of eGFR and UACR and the occurrence of myocardial infarction (MI), CHD, stroke, heart failure (HF) and cardiovascular mortality in 13,657 individuals with diabetes (53.6% male, age 62.3±12.1 years) from the Hoorn Diabetes Care System cohort, using data obtained between 1998 and 2018. Multivariate time-dependent Cox regression models adjusted for cardiovascular risk factors were used to estimate HRs and 95% CI. Associations of eGFR were adjusted for UACR values and vice versa. Effect modification by sex was investigated for all associations. RESULTS: After a mean follow-up period of 7 years, event rates per 1000 person-years were 3.08 for MI, 3.72 for CHD, 1.12 for HF, 0.84 for stroke and 6.25 for cardiovascular mortality. Mildly reduced eGFR (60-90 ml/min per 1.73 m2) and moderately to severely reduced eGFR (<59 ml/min per 1.73 m2) were associated with higher risks of MI (HR 1.52; 95% CI 1.10, 2.12 and HR 1.69; 95% CI 1.09, 2.64) and CHD (HR 1.67; 95% CI 1.23, 2.26 and HR 2.01; 95% CI 1.34, 3.02) compared with normal eGFR (>90 ml/min per 1.73 m2). Mildly reduced eGFR was associated with a higher risk of stroke (HR 2.53; 95% CI 1.27, 5.03). Moderately increased UACR (3-30 mg/mmol) and severely increased UACR (>30 mg/mmol) were prospectively associated with a higher cardiovascular mortality risk in men and women (HR 1.87; 95% CI 1.41, 2.47 and HR 2.78; 95% CI 1.78, 4.34) compared with normal UACR (<3 mg/mmol). Significant effect modification by sex was observed for the association between UACR and HF. Because there were a limited number of HF events within the category of UACR >30 mg/mmol, categories were combined into UACR <3.0 and >3.0 mg/mmol in the stratified analysis. Women but not men with UACR >3.0 mg/mmol had a significantly higher risk of HF compared with normal UACR (HR 2.79; 95% CI 1.47, 5.28). CONCLUSIONS/INTERPRETATION: This study showed differential and independent prospective associations between manifestations of early kidney damage in diabetes and several CVD subtypes, suggesting that regular monitoring of both kidney function measures may help to identify individuals at higher risk of specific cardiovascular events.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Dal Canto E, Elders PJM, van der Heijden AA, et al. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort. Diabetologia. 2022. PMID: 36347992. doi:10.1007/s00125-022-05826-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。